Susquehanna International Group
PRAH

Susquehanna International Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Susquehanna International Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,700
Closed -$942K – 14137
2021
Q2 		$942K Buy
5,700
+1,000
+21% +$167K ﹤0.01% 7937
2021
Q1 		$721K Buy
4,700
+100
+2% +$13.6K ﹤0.01% 8584
2020
Q4 		$577K Sell
4,600
-41,200
-90% -$4.61M ﹤0.01% 7971
2020
Q3 		$4.65M Buy
45,800
+2,000
+5% +$204K ﹤0.01% 3147
2020
Q2 		$4.26M Buy
43,800
+6,100
+16% +$568K ﹤0.01% 3236
2020
Q1 		$3.13M Buy
37,700
+29,400
+354% +$2.87M ﹤0.01% 3221
2019
Q4 		$923K Sell
8,300
-44,900
-84% -$4.62M ﹤0.01% 5684
2019
Q3 		$5.28M Buy
53,200
+14,600
+38% +$1.45M ﹤0.01% 2653
2019
Q2 		$3.83M Sell
38,600
-21,300
-36% -$2.03M ﹤0.01% 3089
2019
Q1 		$6.61M Buy
59,900
+40,600
+210% +$4.24M ﹤0.01% 2146
2018
Q4 		$1.77M Sell
19,300
-14,800
-43% -$1.5M ﹤0.01% 3699
2018
Q3 		$3.76M Buy
34,100
+24,300
+248% +$2.53M ﹤0.01% 3051
2018
Q2 		$915K Buy
9,800
+4,700
+92% +$405K ﹤0.01% 5539
2018
Q1 		$423K Sell
5,100
-4,200
-45% -$373K ﹤0.01% 6973
2017
Q4 		$847K Sell
9,300
-3,800
-29% -$316K ﹤0.01% 5569
2017
Q3 		$998K Sell
13,100
-3,200
-20% -$242K ﹤0.01% 5271
2017
Q2 		$1.22M Buy
16,300
+6,300
+63% +$437K ﹤0.01% 4851
2017
Q1 		$652K Buy
10,000
+2,300
+30% +$135K ﹤0.01% 5992
2016
Q4 		$424K Sell
7,700
-19,200
-71% -$1.05M ﹤0.01% 7321
2016
Q3 		$1.52M Buy
26,900
+12,000
+81% +$588K ﹤0.01% 4013
2016
Q2 		$622K Buy
14,900
+6,300
+73% +$290K ﹤0.01% 5762
2016
Q1 		$368K Buy
+8,600
New +$363K ﹤0.01% 6918
2015
Q4 		– Sell
-7,400
Closed -$287K – 10205
2015
Q3 		$287K Sell
7,400
-7,400
-50% -$296K ﹤0.01% 8113
2015
Q2 		$538K Buy
14,800
+2,900
+24% +$91.7K ﹤0.01% 7495
2015
Q1 		$343K Buy
+11,900
New +$332K ﹤0.01% 7733

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Susquehanna International Group's PRAH Position: Q3 2021 in Review

Susquehanna International Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 622,837 shares — an estimated $103M sold.

Susquehanna International Group first reported a position in PRAH in Q4 2014 and held it in 18 quarters. The position peaked at $103M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Susquehanna International Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Susquehanna International Group sold 622,837 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $103M.
  • Susquehanna International Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 18 quarters.
  • Susquehanna International Group's PRA Health Sciences, Inc. position peaked at $103M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.